Early research (Phase 1)Study completedNCT00426712
What this trial is testing
Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients
Who this might be right for
Hepatitis B
Dynavax Technologies Corporation 42
Showing 20 of 0 results